These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1887508)

  • 1. Ultrasound properties of liver with and without particulate contrast agents.
    Tuthill TA; Baggs RB; Violante MR; Parker KJ
    Ultrasound Med Biol; 1991; 17(3):231-7. PubMed ID: 1887508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particulate suspensions as ultrasonic contrast agents for liver and spleen.
    Violante MR; Parker KJ; Fischer HW
    Invest Radiol; 1988 Sep; 23 Suppl 1():S294-7. PubMed ID: 3058633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A particulate contrast agent with potential for ultrasound imaging of liver.
    Parker KJ; Tuthill TA; Lerner RM; Violante MR
    Ultrasound Med Biol; 1987 Sep; 13(9):555-66. PubMed ID: 3318074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound contrast for hepatic tumors using IDE particles.
    Parker KJ; Baggs RB; Lerner RM; Tuthill TA; Violante MR
    Invest Radiol; 1990 Oct; 25(10):1135-9. PubMed ID: 2079414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate contrast media for computed tomographic scanning of the liver.
    Violante MR; Dean PB; Fischer HW; Mahoney JA
    Invest Radiol; 1980; 15(6 Suppl):S171-5. PubMed ID: 7203919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomographic enhancement of liver and spleen in the dog with iodipamide ethyl ester particulate suspensions.
    Sands MS; Violante MR; Gadeholt G
    Invest Radiol; 1987 May; 22(5):408-16. PubMed ID: 3597009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic backscatter properties of the particle/bubble ultrasound contrast agent.
    Phillips D; Chen X; Baggs R; Rubens D; Violante M; Parker KJ
    Ultrasonics; 1998 Jul; 36(8):883-92. PubMed ID: 9695767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and evaluation of ioxilan carbonate particles for computed tomography contrast enhancement of liver.
    Li C; Kan Z; Yang DJ; Kuang LR; Liu CW; Wright KC; Wallace S
    Invest Radiol; 1994 Nov; 29(11):1006-13. PubMed ID: 7890508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast agents in diagnostic ultrasound.
    Ophir J; Parker KJ
    Ultrasound Med Biol; 1989; 15(4):319-33. PubMed ID: 2669297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and dissolution of particulate iodipamide ethyl ester in the spleen. A morphologic study.
    Lauteala L; Kormano M; Violante MR
    Invest Radiol; 1987 Oct; 22(10):829-35. PubMed ID: 3429178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New media. Particulate contrast media.
    Violante MR; Fischer HW; Mahoney JA
    Invest Radiol; 1980; 15(6 Suppl):S329-34. PubMed ID: 7203945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrasound contrast agents for liver diagnostics].
    Lemke AJ; Chopra SS; Niehues SM; Felix R
    Radiologe; 2005 Jun; 45(6):520-8. PubMed ID: 15912323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: a pilot animal study.
    Li J; Dong BW; Yu XL; Wang XH; Li CF
    J Ultrasound Med; 2005 Jul; 24(7):975-83. PubMed ID: 15972712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound of the liver.
    Kono Y; Mattrey RF
    Radiol Clin North Am; 2005 Sep; 43(5):815-26, vii. PubMed ID: 16098341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grey-scale contrast enhancement in rabbit liver with SonoVue at different doses.
    Li J; Dong B; Yu X; Wang X; Li C
    Ultrasound Med Biol; 2005 Feb; 31(2):185-90. PubMed ID: 15708457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles as image enhancing agents for ultrasonography.
    Liu J; Levine AL; Mattoon JS; Yamaguchi M; Lee RJ; Pan X; Rosol TJ
    Phys Med Biol; 2006 May; 51(9):2179-89. PubMed ID: 16625034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between IEEC, a new biodegradable particulate contrast medium, and iohexol in a tumor model of computed tomography imaging of the liver.
    Leander P; Golman K; Strande P; Klaveness J; Besjakov J; Fält K
    Invest Radiol; 1993 Jun; 28(6):513-9. PubMed ID: 8320069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of biliary x-ray contrast agents in computed tomography.
    Evill CA; Wilson BC; Benness GT
    Australas Radiol; 1983 Nov; 27(3):258-62. PubMed ID: 6675660
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and characterization of a nanoscale ultrasound contrast agent.
    Wang D; Yang K; Gao YH; Tan KB; Liu Z
    Clin Imaging; 2010; 34(4):288-92. PubMed ID: 20630341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemocoagulase Combined with Microbubble-Enhanced Ultrasound Cavitation for Augmented Ablation of Microvasculature in Rabbit VX2 Liver Tumors.
    Yang Q; Tang P; He G; Ge S; Liu L; Zhou X
    Ultrasound Med Biol; 2017 Aug; 43(8):1658-1670. PubMed ID: 28545858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.